Baranowski Lyn 4
4 · Rani Therapeutics Holdings, Inc. · Filed May 27, 2022
Insider Transaction Report
Form 4
Baranowski Lyn
Director
Transactions
- Award
Stock Option (Right to Buy)
2022-05-25+22,240→ 22,240 totalExercise: $10.89Exp: 2032-05-24→ Class A Common Stock (22,240 underlying)
Footnotes (1)
- [F1]The shares subject to the option vest in full on the first anniversary of the date of grant, subject to the recipient's Continuous Service (as defined in the Company's 2021 Equity Incentive Plan) through such vesting date; provided, that, if earlier, the shares subject to the option will vest in full upon the occurrence of either of the following events: the Company's next annual stockholder meeting or a Change in Control (as defined in the 2021 Equity Incentive Plan).